Peptides Are Having a Moment
Peptides Are Having a Moment April 8, 2026 In the first week of April 2026, something happened that doesn’t normally
Viking Therapeutics, Amgen, and the Next-Generation Obesity Pipeline
While Eli Lilly consolidates its lead in the obesity therapeutics market, a second wave of companies is advancing candidates that
A Patient Chose BPC-157 Over a Statin. A STAT News Physician Asks Why.
A physician writing in STAT News on April 3 described a patient who refuses to take a statin — a drug
FDA Approves Foundayo (Orforglipron) — First Oral GLP-1 for Weight Loss With No Food or Water Restrictions
The FDA approved Eli Lilly’s Foundayo (orforglipron) on April 1, 2026, making it the first oral GLP-1 receptor agonist for
NPR Investigates Unregulated Peptides Sold Directly from Chinese Factories
An NPR/WBUR investigation published March 24 documented the pipeline through which unregulated peptides move from Chinese manufacturing facilities to American
Retatrutide Phase 3 Delivers 26% Weight Loss — But a New Safety Signal Emerges
Eli Lilly’s retatrutide — the first triple-hormone-receptor agonist (GLP-1, GIP, and glucagon) — posted striking Phase 3 results from the TRIUMPH program,
FDA Approves Icotyde — First Targeted Oral Peptide for Psoriasis
The FDA approved Icotyde (icotrokinra) on March 18, 2026, for moderate-to-severe plaque psoriasis in adults and adolescents aged 12 and
FDA Sharpens Enforcement on Compounded GLP-1 Drugs as Shortage Era Ends
The FDA has publicly signaled its intent to take enforcement action against non-approved GLP-1 drugs — a shift that follows the
Two New Systematic Reviews Confirm BPC-157’s Preclinical Promise — and Its Human Evidence Gap
Two recently published reviews have mapped the full landscape of BPC-157 research — and the picture they paint is simultaneously impressive
HHS Announces Peptide Reclassification — 14 Compounds Returning to Legal Compounding
On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. announced that approximately 14 of the 19 peptides previously placed